X-Chem Announces Acquisition of Glamorous AI

X-Chem has announced its acquisition of Glamorous AI, a company that uses artificial intelligence (AI) in drug discovery research. X-Chem will combine the tool with its DNA-encoded library (DEL) platform to advance research into novel therapeutic targets and to improve patient outcomes.

Glamorous AI CEO Noor Shaker remarks, “X-Chem generates billions of high-quality data points with its DEL platform, and we provide the capability to build the best AI to unlock the power of those data. It is when such large datasets come together with a powerful technology like AI that transformation happens,” adding, “This aligns very well with our vision to democratize access to AI and to provide a fully-integrated service for the biopharma industry.” Read more here.

(Source: X-Chem, 10/28/21)